Header Logo

Connection

Ed Barker to T-Lymphocytes

This is a "connection" page, showing publications Ed Barker has written about T-Lymphocytes.
Connection Strength

1.226
  1. Degranulation of natural killer cells following interaction with HIV-1-infected cells is hindered by downmodulation of NTB-A by Vpu. Cell Host Microbe. 2010 Nov 18; 8(5):397-409.
    View in: PubMed
    Score: 0.355
  2. HIV modulates the expression of ligands important in triggering natural killer cell cytotoxic responses on infected primary T-cell blasts. Blood. 2007 Aug 15; 110(4):1207-14.
    View in: PubMed
    Score: 0.279
  3. Killing of human immunodeficiency virus-infected primary T-cell blasts by autologous natural killer cells is dependent on the ability of the virus to alter the expression of major histocompatibility complex class I molecules. Blood. 2004 Oct 01; 104(7):2087-94.
    View in: PubMed
    Score: 0.226
  4. A Conserved HIV-1-Derived Peptide Presented by HLA-E Renders Infected T-cells Highly Susceptible to Attack by NKG2A/CD94-Bearing Natural Killer Cells. PLoS Pathog. 2016 Feb; 12(2):e1005421.
    View in: PubMed
    Score: 0.127
  5. Lysis of antigenically unrelated tumor cells mediated by Lyt 2+ splenic T-cells from melphalan-cured MOPC-315 tumor bearers. Cancer Res. 1989 Sep 15; 49(18):5007-15.
    View in: PubMed
    Score: 0.082
  6. Importance of Lyt-2+ T-cells in the resistance of melphalan-cured MOPC-315 tumor bearers to a challenge with MOPC-315 tumor cells. Cancer Res. 1988 Sep 01; 48(17):4834-42.
    View in: PubMed
    Score: 0.076
  7. Plasma viral load, CD4+ cell counts, and HIV-1 production by cells. Science. 1996 Feb 02; 271(5249):670-1.
    View in: PubMed
    Score: 0.032
  8. Phorbol ester-induced enhancement in lytic activity of CD8+ splenic T cells from low-dose melphalan-treated MOPC-315-tumor bearers. Cancer Immunol Immunother. 1991; 32(6):353-63.
    View in: PubMed
    Score: 0.022
  9. Eradication of a large MOPC-315 tumor in athymic nude mice by chemoimmunotherapy with Lyt2+ splenic T cells from melphalan-treated BALB/c mice bearing a large MOPC-315 tumor. Cancer Immunol Immunother. 1990; 31(3):129-38.
    View in: PubMed
    Score: 0.021
  10. Importance of Lyt 2+ T-cells in the curative effectiveness of a low dose of melphalan for mice bearing a large MOPC-315 tumor. Cancer Res. 1989 Aug 15; 49(16):4597-606.
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.